Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (241-250 of 277) with videos related to

Pageof 28
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRSSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
International Journal of Molecular Sciences|May 13, 2023
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Rob Ter Horst, et al.
American Journal of Hematology|January 13, 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R Cerhan, Matthew J Maurer, Brian K Link, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Joshua N Sampson, James R Cerhan, et al.
American Journal of Epidemiology|February 26, 2015
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
Blood|April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.
Blood Advances|September 3, 2025
Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemiaAntonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Juan José Rodríguez-Sevilla, et al.
Plos Genetics|May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaKarin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
International Journal of Cancer|March 6, 2021
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patientsAngelica Macauda, Chiara Piredda, Alyssa I Clay-Gilmour, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.
Pageof 28

Showing results (241-250 of 277) with videos related to

Sort By:
Pageof 28
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRSSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
International Journal of Molecular Sciences|May 13, 2023
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Rob Ter Horst, et al.
American Journal of Hematology|January 13, 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R Cerhan, Matthew J Maurer, Brian K Link, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Joshua N Sampson, James R Cerhan, et al.
American Journal of Epidemiology|February 26, 2015
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
Blood|April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.
Blood Advances|September 3, 2025
Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemiaAntonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Juan José Rodríguez-Sevilla, et al.
Plos Genetics|May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaKarin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
International Journal of Cancer|March 6, 2021
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patientsAngelica Macauda, Chiara Piredda, Alyssa I Clay-Gilmour, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.
Pageof 28